4//SEC Filing
Louie Ngar Yee 4
Accession 0001127602-24-010325
CIK 0001878313other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:09 PM ET
Size
7.0 KB
Accession
0001127602-24-010325
Insider Transaction Report
Form 4
Louie Ngar Yee
Director
Transactions
- Purchase
Warrants
2024-03-14$1.30/sh+170,940$222,222→ 170,940 totalExercise: $1.30From: 2024-09-14Exp: 2029-09-14→ Common Stock (170,940 underlying) - Purchase
Common Stock
2024-03-14$1.17/sh+170,940$200,000→ 1,147,524 total
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.
- [F2]The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024. The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913264
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:09 PM ET
- Size
- 7.0 KB